Virtual Training Works Just as Well as In-Person for the MiniMed 780G Insulin Pump

Researchers at Hospital Universitario San Ignacio in Bogotá, Colombia wanted to answer an important practical question: Does it matter whether people learn to use the MiniMed 780G insulin pump in person or online?

The MiniMed 780G is an advanced hybrid closed-loop system—a type of 'smart' insulin pump that automatically adjusts insulin delivery based on blood sugar levels. The study looked at 191 adults with Type 1 diabetes, roughly half trained virtually and half trained in person. Researchers tracked their blood sugar control and safety outcomes for 12 weeks after starting the pump.

After 12 weeks, the results were remarkably similar between groups. The virtual training cohort achieved a time in range (TIR) of 75%—meaning blood sugar stayed in the target zone of 70–180 mg/dL for 75% of the day. The in-person training group achieved 77.5% TIR. This difference was not statistically significant.

Both groups also saw meaningful improvements in safety. Severe hypoglycemic events—dangerously low blood sugar readings below 54 mg/dL—decreased significantly in both the virtual and in-person groups. Again, there was no meaningful difference between the two approaches.

When researchers analyzed the data more carefully, they found that the type of training (virtual vs. in-person) was not significantly associated with achieving blood sugar goals. Instead, other factors played a role.

Younger age (under 45 years) was independently associated with better metabolic control. Higher socioeconomic status showed a trend toward better outcomes, though this finding was less definitive.

These results suggest that access barriers—such as distance or inability to attend in-person appointments—should not prevent people from successfully learning to use this technology.

For people considering the MiniMed 780G or similar advanced insulin pumps, this study offers reassurance: training format appears to be far less important than once thought. Virtual training can be just as effective as in-person instruction for learning to use and manage this system.

The significant reduction in severe hypoglycemia in both groups is also encouraging, showing that the pump technology itself—when properly initiated—can meaningfully improve safety for adults with Type 1 diabetes, regardless of how they receive their training.

Source: Clinical medicine insights. Endocrinology and diabetes. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.